Complementary & Integrative Medicine · English patient guide
Integrative Oncology and Traditional Chinese Medicine: A Safety-Focused Patient Guide
A plain-language introduction to a 2,000-year medical tradition, written for international patients who want to discuss complementary care alongside standard oncology treatment.
Complementary care · clinician review · never a substitute for oncology treatment
Complementary, coordinated and individualized
Traditional Chinese Medicine (TCM) is a distinct medical tradition. In cancer care, any complementary use should be considered alongside—not instead of—surgery, chemotherapy, radiation, targeted therapy, immunotherapy and other standard care. Evidence and safety vary by intervention and patient.
What a consultation can do
Organize your current treatment and symptoms, discuss supportive-care priorities, review potential interaction risks and identify questions to coordinate with your oncology team.
What it will not do
It will not ask you to abandon effective treatment, replace your local doctors or promise a cure. Decisions remain yours to make with your treating clinicians.
A short history of the tradition
Historical importance is not proof that every modern product or claim is effective. The timeline is included for context, not as a treatment recommendation.
- c. 300 BCE
- The Yellow Emperor's Inner Canon — a foundational text describing a holistic view of health and illness.
- c. 200 CE
- Treatise on Cold Damage — associated with syndrome differentiation and formula-based discussion.
- 1406
- Puji Fang — a large Ming-era formulary whose name means “universal relief”.
- 1578
- Compendium of Materia Medica — Li Shizhen's extensive historical materia-medica work.
- Today
- Online discussion — eligible international patients may discuss this tradition with a China-based clinician; any medicine or delivery requires separate, destination-specific review.
Traditional terms, explained cautiously
These concepts are frameworks for discussion. They are not promises of a biological effect, tumor control or treatment outcome.
扶正祛邪Fú Zhèng Qū Xié · resilience frameworkA traditional way to discuss resilience and illness; not proof of “boosting immunity”.
辨证论治Biàn Zhèng Lùn Zhì · individualizationA pattern-based method for structuring an individualized clinical discussion.
活血化瘀Huó Xuè Huà Yū · circulation conceptA traditional concept; it does not itself demonstrate a measurable change in blood flow or tumor biology.
减毒增效Jiǎn Dú Zēng Xiào · supportive-care goalA goal discussed in traditional practice, not a guaranteed result for any patient.
Evidence is specific—and has limits
Authoritative sources publish guidance for specific complementary approaches. That does not mean every herb, formula, product, claim or provider is supported by evidence.
NCCIH safety guidance
Complementary approaches should not replace or delay cancer treatment, and some products can interfere with treatment.
SIO–ASCO pain guideline
The 2022 guideline evaluates specific integrative interventions for oncology pain; it does not validate every complementary therapy.
NCI interaction guidance
Herbs and dietary supplements can alter how some anticancer medicines work and may cause adverse reactions.
Keep claims narrow
A study of one modality, symptom or population cannot be generalized to every product, formula, cancer type or individual patient.
Evidence applies to specific interventions, outcomes and patients—not to an entire tradition as one treatment.
NCCIH: Cancer and Complementary Health Approaches · SIO–ASCO Oncology Pain Guideline · NCI: Cancer Therapy and Supplement Interactions
Questions patients commonly bring
These are supportive-care concerns to discuss with qualified clinicians, not promised outcomes.
- Treatment-related nausea, mouth discomfort, skin or bowel changes.
- Fatigue, sleep, appetite, digestion and daily function.
- Pain patterns and questions to take to the treating team.
- Blood counts, infection concerns and laboratory-result review.
- Recovery questions after surgery and quality-of-life priorities.
Built around your safety
Safety depends on knowing your diagnosis, medicines, current treatment and local oncology plan.
- Bring a complete list of Western medicines, targeted therapy, immunotherapy, supplements and allergies.
- Potential herb–drug interactions must be screened before any herbal support is considered.
- Keep your local treating physicians informed and coordinate decisions with them.
- Do not delay standard treatment, and seek local emergency care for urgent symptoms.
For English-speaking international patients
PujiCAM can arrange a private video discussion with a China-based clinician for eligible international patients. The USD $30 fee covers one consultation and care-direction discussion; it does not include diagnosis, prescriptions, medicines, tests, travel, treatment packages or a guaranteed outcome.
Country availability, payment, telemedicine rules and any medicine-import questions require separate confirmation. The service is not a local-country medical licence and does not guarantee cross-border prescribing, supply or delivery.
Book the USD $30 consultation · Return to PujiCAM
Published by Chengdu Puji Traditional Chinese Medicine Research Institute · Sources and safety language reviewed 25 July 2026. This page is for education and international intake, not online diagnosis, cure claims or prescriptions.
